Aqr Capital Management LLC Catalyst Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

  • $151 Billion
  • Q3 2025

A detailed history of Aqr Capital Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 337,052 shares of CPRX stock, worth $7.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
337,052
Previous 398,422 15.4%
Holding current value
$7.81 Million
Previous $8.65 Million 23.2%
% of portfolio
0.0%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$19.13 - $22.22 $1.17 Million - $1.36 Million
-61,370 Reduced 15.4%
337,052 $6.64 Million
Q2 2025

Aug 14, 2025
SELL
$21.4 - $26.31 $1.01 Million - $1.24 Million
-47,088 Reduced 10.57%
398,422 $8.65 Million
Q1 2025

May 15, 2025
SELL
$19.53 - $25.74 $615,214 - $810,835
-31,501 Reduced 6.6%
445,510 $10.8 Million
Q4 2024

Feb 14, 2025
BUY
$19.73 - $23.93 $348,412 - $422,579
17,659 Added 3.84%
477,011 $9.96 Million
Q3 2024

Nov 14, 2024
SELL
$15.19 - $21.35 $441,026 - $619,875
-29,034 Reduced 5.94%
459,352 $9.13 Million
Q2 2024

Aug 14, 2024
BUY
$14.68 - $16.92 $3.34 Million - $3.85 Million
227,321 Added 87.07%
488,386 $7.57 Million
Q1 2024

May 15, 2024
SELL
$13.18 - $17.11 $1.08 Million - $1.4 Million
-81,736 Reduced 23.84%
261,065 $4.16 Million
Q4 2023

Feb 14, 2024
SELL
$11.78 - $17.29 $1.58 Million - $2.32 Million
-133,999 Reduced 28.1%
342,801 $5.76 Million
Q3 2023

Nov 14, 2023
SELL
$11.69 - $15.02 $1.94 Million - $2.5 Million
-166,194 Reduced 25.85%
476,800 $5.57 Million
Q2 2023

Aug 14, 2023
BUY
$11.5 - $18.08 $4.36 Million - $6.85 Million
378,770 Added 143.35%
642,994 $8.64 Million
Q1 2023

May 15, 2023
BUY
$14.34 - $21.05 $513,285 - $753,463
35,794 Added 15.67%
264,224 $4.38 Million
Q4 2022

Feb 14, 2023
SELL
$12.25 - $19.5 $2.11 Million - $3.36 Million
-172,201 Reduced 42.98%
228,430 $4.25 Million
Q3 2022

Nov 14, 2022
SELL
$7.06 - $15.52 $613,584 - $1.35 Million
-86,910 Reduced 17.83%
400,631 $5.14 Million
Q2 2022

Aug 15, 2022
BUY
$6.23 - $8.57 $460,951 - $634,085
73,989 Added 17.89%
487,541 $3.42 Million
Q1 2022

May 16, 2022
SELL
$5.31 - $8.31 $130,206 - $203,769
-24,521 Reduced 5.6%
413,552 $3.43 Million
Q4 2021

Feb 14, 2022
SELL
$5.21 - $7.45 $194,041 - $277,467
-37,244 Reduced 7.84%
438,073 $2.97 Million
Q3 2021

Nov 15, 2021
BUY
$4.85 - $6.04 $732,927 - $912,758
151,119 Added 46.61%
475,317 $2.52 Million
Q2 2021

Aug 16, 2021
SELL
$4.29 - $6.05 $1.71 Million - $2.42 Million
-399,455 Reduced 55.2%
324,198 $1.86 Million
Q1 2021

May 17, 2021
SELL
$3.45 - $4.69 $930,734 - $1.27 Million
-269,778 Reduced 27.16%
723,653 $3.34 Million
Q4 2020

Feb 16, 2021
BUY
$2.97 - $3.83 $427,380 - $551,133
143,899 Added 16.94%
993,431 $3.32 Million
Q3 2020

Nov 16, 2020
SELL
$2.97 - $5.08 $165,464 - $283,016
-55,712 Reduced 6.15%
849,532 $2.52 Million
Q2 2020

Aug 17, 2020
SELL
$3.48 - $5.05 $1.07 Million - $1.55 Million
-307,205 Reduced 25.34%
905,244 $4.18 Million
Q1 2020

May 15, 2020
BUY
$2.61 - $5.21 $201,766 - $402,759
77,305 Added 6.81%
1,212,449 $4.67 Million
Q4 2019

Feb 14, 2020
BUY
$3.67 - $5.7 $3.55 Million - $5.52 Million
968,574 Added 581.48%
1,135,144 $4.26 Million
Q3 2019

Nov 14, 2019
SELL
$3.89 - $7.43 $442,946 - $846,039
-113,868 Reduced 40.6%
166,570 $884,000
Q2 2019

Aug 14, 2019
BUY
$2.7 - $6.11 $588,170 - $1.33 Million
217,841 Added 348.01%
280,438 $1.08 Million
Q1 2019

May 14, 2019
SELL
$2.11 - $5.33 $162,986 - $411,715
-77,245 Reduced 55.24%
62,597 $319,000
Q4 2018

Feb 14, 2019
SELL
$1.92 - $3.62 $112,807 - $212,689
-58,754 Reduced 29.58%
139,842 $268,000
Q3 2018

Nov 15, 2018
SELL
$2.81 - $3.78 $496,808 - $668,304
-176,800 Reduced 47.1%
198,596 $751,000
Q2 2018

Aug 14, 2018
SELL
$2.26 - $3.84 $965,700 - $1.64 Million
-427,301 Reduced 53.23%
375,396 $1.17 Million
Q1 2018

May 15, 2018
BUY
$2.39 - $4.01 $1.11 Million - $1.87 Million
466,119 Added 138.49%
802,697 $1.92 Million
Q4 2017

Feb 14, 2018
SELL
$2.51 - $4.4 $40,280 - $70,611
-16,048 Reduced 4.55%
336,578 $1.32 Million
Q3 2017

Nov 14, 2017
BUY
$2.4 - $2.94 $846,302 - $1.04 Million
352,626
352,626 $889,000

Others Institutions Holding CPRX

# of Institutions
392
Shares Held
105M
Call Options Held
164K
Put Options Held
439K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.38B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email